WHO Reviews Its Essential Medicines List; Some New Candidates Under Patent

essential meds

The World Health Organization is reviewing its list of essential medicines this week. Over 70 candidate medicines are expected to be assessed by an Expert Committee. Some of those medicines are under patent and highly priced, which poses an accessibility challenge.

WHO Opens Its Database Of Medicines Side Effects To The Public

safe medicines

The World Health Organization has announced that its Global Medicines Safety Database is now open to the general public. The database named VigiAccess can now be accessed on any computer or smartphone in the world.

Experts Debate Medicines Access In South Africa And Beyond

ficpi cape town

CAPE TOWN – Pharmaceutical patents and access to medicines was the focus of an animated panel discussion by experts offering divergent views on the topic at intellectual property group FICPI’s 2015 World Congress, currently underway in Cape Town, South Africa.

Clinical Trial Transparency, Medicines Access On Agendas Today

Gilead Solvaldi tablet

The World Health Organization today issued a call for disclosure of results from clinical trials for medical products, no matter what the results of the trials were. And a variety of events and publications are addressing medicines access today.

WHO Issues Guideline For Manufacturers Of Generic Hepatitis C Medicine

Medicines - Flickr - Doug88888

The World Health Organization has issued a guidance document on the design of bioequivalence studies for a leading hepatitis C medicine. Generic drug companies seeking prequalification by the WHO need to demonstrate that their generic version is equivalent to the originator drug.

Supplier of Essential Medicines Supports TRIPS Waiver For Least-Developed Countries

Medicines - Flickr - Laura Gilmore

The IDA Foundation, a worldwide supplier of essential medicines to low-and medium income countries, has backed up the request by least-developed countries to extend a waiver that allows them to forfeit the obligations to protect intellectual property on pharmaceutical products. UNITAID, the UN-related drug purchasing mechanism, also issued a statement in support of the extension. The request is expected to be discussed at the World Trade Organization in June.

Indian Draft Pesticides Bill Contains TRIPS-Plus Data Exclusivity, Indian Pharma Says

Medicines - Flickr - Hitthatswich

India is considering legislation on pesticides containing data exclusivity provisions that would raise the level of intellectual property protection above the minimum required by international trade agreements and could act as a precursor for pharmaceutical products in the country, a leading Indian industry representative warned this week. India is sensitive to restrictions on the use of marketing data of patented pharmaceuticals as it is seen as the world leader in generic medicines, which use such data.

Open Source Model In Computers Should Be Applied To Genomic Data, Paper Says

Plant genome  1

Genomic data should be made publicly available for the promotion of science as a global public good, a new paper argues. Two researchers suggest that a model inspired by the open-source computer software movement should be developed for plant breeding, animal breeding, and biomedicine.

Redesign Of Ebola Treatment Units Draws 1500 Innovations, Including Locally

Structural view of the redesigned Ebola treatment tent

KAMPALA, UGANDA – In light of the persistence of the Ebola outbreak and the demands it has placed on global infection containment resources and processes, the United States government disaster response community recognised an opportunity to use open innovation to make significant strides in advancing the ability to combat Ebola. The results include a local success story.

Global Fund Publishes Terms Of Reference Of Equitable Access Initiative

Global Fund

An initiative spearheaded by the Global Fund for AIDS, Tuberculosis and Malaria to ensure equitable access to medicines in particular in middle-income countries now has a dedicated webpage publishing the terms of reference of the initiative. Also available is the list of high-level participants who attended the first meeting of the initiative held last week.